Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

1.57
Delayed Data
As of May 27
 +0.02 / +1.29%
Today’s Change
1.29
Today|||52-Week Range
8.50
-66.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization76.0K72.0K100.0K107.0K
 
 
 
 
 
 
Operating ExpensesGross Income-76.0K-72.0K-100.0K-107.0K
 
 
 
 
 
General Expenses12.2M15.2M17.6M18.5M
 
 
 
 
 
Research And Development8.9M11.8M14.4M14.8M
 
 
 
 
 
Total Operating Expenses12.2M15.3M17.7M18.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.2M-15.3M-17.7M-18.6M
 
 
 
 
 
Other Expenses-13.0K-20.0K-17.0K-16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.9M-14.9M-17.2M-18.0M
 
 
 
 
 
Net Income-11.9M-14.9M-17.2M-18.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.0M24.0M29.0M32.8M
 
 
 
 
 
Shares To Calculate EPS Diluted22.0M24.0M29.0M32.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.54-$0.62-$0.59-$0.55
 
 
 
 
 
EPS Diluted-$0.54-$0.62-$0.59-$0.55